+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

From
Hemophilia Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

Hemophilia Market - Forecasts from 2023 to 2028

  • Report
  • December 2023
  • 143 Pages
  • Global
From
From
From
From
Hypodermic Needles Market 2024-2028 - Product Thumbnail Image

Hypodermic Needles Market 2024-2028

  • Report
  • July 2024
  • 166 Pages
  • Global
From
Rnai Drug Delivery Market 2024-2028 - Product Thumbnail Image

Rnai Drug Delivery Market 2024-2028

  • Report
  • July 2024
  • 180 Pages
  • Global
From
Marine Enzymes Market 2024-2028 - Product Thumbnail Image

Marine Enzymes Market 2024-2028

  • Report
  • November 2023
  • 179 Pages
  • Global
From
Global Markets for Bioengineered Protein Drugs - Product Thumbnail Image

Global Markets for Bioengineered Protein Drugs

  • Report
  • March 2023
  • 185 Pages
  • Global
From
From
From
From
From
From
From
Philippines Diabetes Care Devices Market Report and Forecast 2024-2032 - Product Thumbnail Image

Philippines Diabetes Care Devices Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 160 Pages
  • Philippines
From
Poc Hba1C Testing Global Market Report 2024 - Product Thumbnail Image

Poc Hba1C Testing Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
From
Injection Pen Market 2024-2028 - Product Thumbnail Image

Injection Pen Market 2024-2028

  • Report
  • October 2023
  • 172 Pages
  • Global
From
Loading Indicator